Zhongping Duan

411 citations
28 papers · 222 indexed · h-index 10
Topics
Liver Disease Diagnosis and Treatment (18 papers)Liver Disease and Transplantation (7 papers)Drug-Induced Hepatotoxicity and Protection (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Zhongping Duan

27 papers receiving 214 citations

Peers

Zhongping Duan
Comparison fields: 5 of 58
  • Epidemiology 88
  • Molecular Biology 64
  • Hepatology 61
  • Surgery 42
  • Physiology 35
Replace CP Day with:
CP Day United Kingdom
Haoran Ding China
Guang Fu China
Lungen Lu China
V. Vero Italy
Franziska Wandrer Germany
Hui-Min Yan China
Tien‐Yu Huang Taiwan
Yaron Arbel Israel
Yusuke Tsuchimoto Japan
Zhongping Duan relative to CP Day United Kingdom CP Day's profile →
Citations per field
00.5×
CP Day · 1×
Citations per year

Countries citing papers authored by Zhongping Duan

Since Specialization
Citations

This map shows the geographic impact of Zhongping Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongping Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongping Duan more than expected).

Fields of papers citing papers by Zhongping Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongping Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongping Duan. The network helps show where Zhongping Duan may publish in the future.

Co-authorship network of co-authors of Zhongping Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongping Duan. A scholar is included among the top collaborators of Zhongping Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongping Duan. Zhongping Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 4
4 9
5 20
6 5
7 15
8 24
9 6
10 1
11 19
12 9
13 2
14 1
15 27
16 18
17 3
18 19
19
[Establishment of a D-galactosamine/lipopolysaccharide induced acute-on-chronic liver failure model in rats].
11
20 11

About Zhongping Duan

Zhongping Duan is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 28 papers that have together received 222 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Liver Disease and Transplantation (7 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). The work is most often cited by research in Hepatology (61 citations), Pharmacology (31 citations) and Epidemiology (88 citations). Zhongping Duan has collaborated with scholars based in China and United States. Frequent co-authors include Feng Ren, Sujun Zheng, Liyan Chen, Li Zhou, Cheng Zhang, Xiaolin Huo, Shuang Liu, Pengfei Yu, Yu Chen and Jian‐xing Ma. Their work appears in journals such as Scientific Reports, Journal of Hepatology and World Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026